Market Tracker

04/01 5:11am ET

ImmunoGen Inc (NASDAQ:IMGN)

8.95
Delayed Data
As of Mar 31
 +0.43 / +5.05%
Today’s Change
5.34
Today|||52-Week Range
15.59
+46.72%
Year-to-Date

Today’s Trading

Previous close8.52
Today’s open8.89
Day’s range-- - --
Volume4,814,763
Average volume (3 months)1,648,159
Market cap$733.6M
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+20.78%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book9.67

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...+0.26+1.00%
ANIPANI Pharmaceuticals ...-0.38-0.60%
AERIAerie Pharmaceutical...+0.07+0.22%
RTRXRetrophin Inc-0.20-0.83%
Data as of 03/31/2015

Financials

Next reporting dateApril 24, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts